The study shows that the susceptibility gene of ENKTCL is the HLA-DPB1 gene, suggesting that ENKTCL have distinct pathogenic mechanisms with NPC or HL [30]. This evidence concerns the gene HLA-DPB1 and Hodgkins lymphoma.